Squarepoint
KROS icon

Squarepoint’s Keros Therapeutics KROS Stock Holding History

Squarepoint’s Portfolio KROS Stock Details KROS Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$1.58M Buy
2025
Q2 		– Sell
2025
Q1 		$448K Buy
2024
Q4 		– Sell
2024
Q3 		$263K Sell
2024
Q2 		$906K Buy
2022
Q4 		– Sell
2022
Q3 		$749K Buy
2022
Q2 		$489K Buy
2021
Q1 		– Sell
2020
Q4 		$637K Buy